Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules
Clinical trial NCT00721396 · COMPLETED
Trial details
- NCT number
- NCT00721396
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2010-07-01
- Enrollment
- 1885
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.